Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy M Sherertz

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|August 9, 2014
Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2-IIIB Cervical CancerCharles A Kunos, Tracy M Sherertz
Journal of Neurobiology|January 1, 2005
Odorant-specific requirements for arrestin function in Drosophila olfactionC Elaine Merrill, Tracy M Sherertz, William B Walker, et al.
BMC Urology|March 6, 2007
Differential expression of CD10 in prostate cancer and its clinical implicationMarc A Dall'Era, Lawrence D True, Andrew F Siegel, et al.
Frontiers in Oncology|June 23, 2015
Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic CancerCharles A Kunos, Tracy M Sherertz, Mazen Mislmani, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|August 9, 2014
Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2-IIIB Cervical CancerCharles A Kunos, Tracy M Sherertz
Journal of Neurobiology|January 1, 2005
Odorant-specific requirements for arrestin function in Drosophila olfactionC Elaine Merrill, Tracy M Sherertz, William B Walker, et al.
BMC Urology|March 6, 2007
Differential expression of CD10 in prostate cancer and its clinical implicationMarc A Dall'Era, Lawrence D True, Andrew F Siegel, et al.
Frontiers in Oncology|June 23, 2015
Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic CancerCharles A Kunos, Tracy M Sherertz, Mazen Mislmani, et al.
Pageof 1